PT75777B - Process for the preparation of a composition for topical treatment of glaucoma and ocular hypertension - Google Patents

Process for the preparation of a composition for topical treatment of glaucoma and ocular hypertension

Info

Publication number
PT75777B
PT75777B PT75777A PT7577782A PT75777B PT 75777 B PT75777 B PT 75777B PT 75777 A PT75777 A PT 75777A PT 7577782 A PT7577782 A PT 7577782A PT 75777 B PT75777 B PT 75777B
Authority
PT
Portugal
Prior art keywords
glaucoma
preparation
composition
topical treatment
ocular hypertension
Prior art date
Application number
PT75777A
Other languages
English (en)
Portuguese (pt)
Other versions
PT75777A (en
Inventor
Otto W Woltersdorf Jr
Stuart R Michelson
John M Sondey
Harvey Schwam
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PT75777A publication Critical patent/PT75777A/pt
Publication of PT75777B publication Critical patent/PT75777B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/76—Sulfur atoms attached to a second hetero atom
    • C07D277/80—Sulfur atoms attached to a second hetero atom to a nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT75777A 1981-11-03 1982-11-02 Process for the preparation of a composition for topical treatment of glaucoma and ocular hypertension PT75777B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/317,807 US4386098A (en) 1981-11-03 1981-11-03 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure

Publications (2)

Publication Number Publication Date
PT75777A PT75777A (en) 1982-12-01
PT75777B true PT75777B (en) 1986-01-15

Family

ID=23235348

Family Applications (1)

Application Number Title Priority Date Filing Date
PT75777A PT75777B (en) 1981-11-03 1982-11-02 Process for the preparation of a composition for topical treatment of glaucoma and ocular hypertension

Country Status (16)

Country Link
US (1) US4386098A (index.php)
EP (1) EP0079269B1 (index.php)
JP (1) JPS5885877A (index.php)
AT (1) ATE19733T1 (index.php)
AU (1) AU555821B2 (index.php)
CA (1) CA1184119A (index.php)
DE (1) DE3271190D1 (index.php)
DK (1) DK486282A (index.php)
FI (1) FI823720L (index.php)
GR (1) GR77056B (index.php)
IE (1) IE54217B1 (index.php)
IL (1) IL67073A0 (index.php)
NO (1) NO823638L (index.php)
NZ (1) NZ202292A (index.php)
PT (1) PT75777B (index.php)
ZA (1) ZA828003B (index.php)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2155331B (en) * 1980-07-09 1988-09-01 Florida University Of Composition for reducing intraocular pressure
US4746745A (en) * 1980-07-09 1988-05-24 Maren Thomas H 1,3,4-thiadiazoline-5-sulfonamides
US4619939A (en) * 1980-07-09 1986-10-28 University Of Florida Process for reducing intraocular pressure
US4454148A (en) * 1982-09-02 1984-06-12 Merck & Co., Inc. 5-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4483864A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
US4975449A (en) * 1983-02-04 1990-12-04 University Of Iowa Research Foundation Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative
US5095026A (en) * 1983-02-04 1992-03-10 University Of Iowa Research Foundation Prodrugs of carbonic anhydrase inhibitors
US4500538A (en) * 1983-03-14 1985-02-19 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4456599A (en) * 1983-04-22 1984-06-26 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4542152A (en) * 1983-05-23 1985-09-17 Merck & Co., Inc. 5-[Phenylsulfonyl(or sulfinyl)]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US4510155A (en) * 1983-06-02 1985-04-09 Merck & Co., Inc. 6(or 5)-Hydroxybenzothiazole-2-sulfonamide-O-sulfate salts for the topical treatment of elevated intraocular pressure
ES8600752A1 (es) * 1983-06-20 1985-10-16 Merck & Co Inc Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
US4585787A (en) * 1983-06-20 1986-04-29 Merck & Co., Inc. 5-[2(Or 3)-hydroxyphenylsulfonyl]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US4486444A (en) * 1983-06-20 1984-12-04 Merck & Co., Inc. (Hydroxybenzoyl)thiophenesulfonamide and acyl derivatives thereof for the topical treatment of elevated intraocular pressure
US4788192A (en) * 1983-06-20 1988-11-29 Merck & Co., Inc. 2-Sulfamoylbenzo(b)thiophene derivatives pharmaceutical compositions and use
NZ208444A (en) * 1983-06-20 1987-08-31 Merck & Co Inc 2-thiophene derivatives and pharmaceutical compositions
US4622403A (en) * 1983-10-11 1986-11-11 Merck Frosst Canada, Inc. 6-H dibenz[b,f]thiepin compounds
US4505923A (en) * 1983-10-31 1985-03-19 Merck & Co., Inc. Ethers of hydroxybenzothiazole-2-sulfonamide for the topical treatment of elevated intraocular pressure
US4668697A (en) * 1983-10-31 1987-05-26 Merck & Co., Inc. Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor
US4544667A (en) * 1984-02-09 1985-10-01 Merck & Co., Inc. 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure
US4840963A (en) * 1984-03-14 1989-06-20 Merck & Co., Inc. 2-Sulfamoyl-1H-indole derivatives for the treatment of elevated intraocular pressure
EP0155214B1 (en) * 1984-03-14 1990-03-14 Merck & Co. Inc. 2-sulfamoyl-1h-indole derivatives for the treatment of elevated intraocular pressure
IT1176613B (it) * 1984-08-14 1987-08-18 Ravizza Spa Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
EP0189690B1 (en) * 1984-12-12 1989-03-01 Merck & Co. Inc. Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
US4929637A (en) * 1985-12-24 1990-05-29 Merck & Co., Inc. Substituted thiophene-2-sulfonamide antiglaucoma agents
US4914111A (en) * 1987-03-23 1990-04-03 Merck & Co., Inc. 4-Benzylthiophene (or furan)-2-sulfonamides as antiglaucoma agents
US4847289A (en) * 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
US4929549A (en) * 1989-02-08 1990-05-29 Merck & Co., Inc. 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors
US5059613A (en) * 1990-03-19 1991-10-22 Research Corporation Technologies, Inc. Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
US5091409A (en) * 1990-05-17 1992-02-25 Merck & Co., Inc. 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides
US5216020A (en) * 1990-10-12 1993-06-01 Merck & Co., Inc. Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides and 6,6-dioxides thereof
SG84487A1 (en) 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
US5300499A (en) * 1992-09-02 1994-04-05 Allergan, Inc. 5-substituted 3-thiophene sulfonamides as antiglaucoma agents
US5519040A (en) * 1994-04-29 1996-05-21 Allergan Substituted thiazole sulfonamides as antiglaucoma agents
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6316443B1 (en) 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
US5789435A (en) * 1995-05-22 1998-08-04 Advanced Research And Technology Institute Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
US6156785A (en) * 1998-01-23 2000-12-05 Merck Sharp & Dohme B.V. Method for increasing oxygen tension in the optic nerve and retina
EP1251862B1 (en) * 2000-01-18 2008-10-01 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US6548535B2 (en) 2000-01-18 2003-04-15 Merck & Co., Inc. Method for treating ocular hypertension
WO2002013800A2 (en) * 2000-08-11 2002-02-21 Einar Stefansson Method for the prevention and treatment of retinopathy
US20040254230A1 (en) * 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
US20050124595A1 (en) * 2002-03-15 2005-06-09 Goetz Michael A. Compositions and methods for treating glaucoma and ocular hypertension
EP1513523A1 (en) * 2002-06-06 2005-03-16 Merck Frosst Canada & Co. 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
CA2488802A1 (en) * 2002-06-14 2003-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO2003105868A1 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. Novel maxi-k channel blockers, methods of use and process for making the same
US7294646B2 (en) * 2002-06-17 2007-11-13 Merck & Co. Inc. Maxi-k channel blockers, methods of use and process for making the same
CA2488845A1 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
AU2003258433A1 (en) * 2002-08-28 2004-03-19 Merck Frosst Canada Ltd Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
JP2006505572A (ja) * 2002-10-25 2006-02-16 メルク フロスト カナダ アンド カンパニー Ｅｐ４受容体アゴニストとしての２−ピロリドン
AU2004226479A1 (en) * 2003-03-27 2004-10-14 Evotec Oai Ophthalmic compositions for treating ocular hypertension
ES2374336T3 (es) * 2007-05-11 2012-02-15 Santen Pharmaceutical Co., Ltd Agente profiláctico o terapéutico para una enfermedad ocular posterior que comprende un agonista selectivo no ergótico del receptor d2 como principio activo.
US8332007B2 (en) * 2009-01-12 2012-12-11 The Board Of Trustees Of The University Of Illinois Quantitative three-dimensional mapping of oxygen tension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2595334A (en) * 1950-04-08 1952-05-06 American Cyanamid Co Benzothiazolesulfonamides and method of preparing the same
US3519630A (en) * 1969-02-06 1970-07-07 Pennsalt Chemicals Corp Antibacterial and antifungal treatment with sulfones
ATE9059T1 (de) * 1980-01-28 1984-09-15 Merck & Co. Inc. Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.

Also Published As

Publication number Publication date
EP0079269B1 (en) 1986-05-14
FI823720A0 (fi) 1982-11-01
AU9004882A (en) 1983-05-12
EP0079269A1 (en) 1983-05-18
FI823720A7 (fi) 1983-05-04
DK486282A (da) 1983-05-04
DE3271190D1 (en) 1986-06-19
IL67073A0 (en) 1983-02-23
FI823720L (fi) 1983-05-04
IE822618L (en) 1983-05-03
AU555821B2 (en) 1986-10-09
IE54217B1 (en) 1989-07-19
ZA828003B (en) 1984-07-25
US4386098A (en) 1983-05-31
GR77056B (index.php) 1984-09-05
CA1184119A (en) 1985-03-19
NO823638L (no) 1983-05-04
ATE19733T1 (de) 1986-05-15
NZ202292A (en) 1986-01-24
PT75777A (en) 1982-12-01
JPS5885877A (ja) 1983-05-23

Similar Documents

Publication Publication Date Title
PT75777A (en) Process for the preparation of a composition for topical treatment of glaucoma and ocular hypertension
EP1225168B8 (en) Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension
AU560189B2 (en) Treatment of ocular hypertension and glaucoma
AU1391683A (en) Treatment of ocular hypertension and glaucoma
GR3004794T3 (index.php)
IE811654L (en) Ophthalmic composition
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
ATE128617T1 (de) Linse für die epikeratophakie und keratotom zum ausführen eines schnittes für die implantation einer solchen linse.
HUT56351A (en) Process for producing pharmaceutical compositions for reducing eye pressure
EP0150063A3 (en) Therapeutic and/or preventive ophthalmic solution for intraocular hypertension and glaucoma
DE3064137D1 (en) Ophthalmic solution for intraocular pressure adjustment
PT75229B (en) Process for preparing benzothiszolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
EP0122178A3 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
GB2100599B (en) Pharmaceutical preparation for treating glaucoma and ocular hypertension
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
DE3472369D1 (en) Use of l-moprolol for the manufacture of a fluid ophthalmic composition for treating glaucoma
AU1966988A (en) Ophthalmic agent and related compositions and method for treatment of the cornea
JO1317B1 (en) Eye treatment
EP0155214A3 (en) 2-sulfamoyl-1h-indole derivatives for the treatment of elevated intraocular pressure
ZA824941B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
EP1300149A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
IT1079483B (it) Composizione oftalmica contenente t-butilammino-3-(morfolino-1,2-tiadiazol-3-ilossi)-2-propanol-maleato acido
AU625096C (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940716